Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.50
Bid: 26.35
Ask: 26.50
Change: 0.00 (0.00%)
Spread: 0.15 (0.569%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 26.50
SHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of New Ordinary Shares

10 Jul 2020 08:04

RNS Number : 6025S
SIG PLC
09 July 2020
 

 

 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, ITS TERRITORIES AND POSSESSIONS, CANADA, JAPAN, SOUTH AFRICA, MALAYSIA, NEW ZEALAND OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND DOES NOT CONSTITUTE A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT. NOTHING HEREIN SHALL CONSTITUTE AN OFFERING OF SHARES. NOTHING IN THIS ANNOUNCEMENT SHOULD BE INTERPRETED AS A TERM OR CONDITION OF THE NEW SHARE ISSUE. ANY DECISION TO PURCHASE, SUBSCRIBE FOR, OTHERWISE ACQUIRE, SELL OR OTHERWISE DISPOSE OF SHARES MUST BE MADE ONLY ON THE BASIS OF THE INFORMATION CONTAINED IN AND INCORPORATED BY REFERENCE INTO THE PROSPECTUS. COPIES OF THE PROSPECTUS ARE AVAILABLE AT WWW.SIGPLC.COM.

 

10 July 2020

SIG plc

(the "Company")

 

Admission of New Ordinary Shares

 

The Company today announces that, pursuant to the CD&R Investment, the Firm Placing and Placing and Open Offer and the Directors and Senior Management Subscription announced on 19 June 2020, 589,999,995 New Ordinary Shares will be admitted to listing on the premium listing segment of the Official List of the Financial Conduct Authority and will be admitted to trading on the London Stock Exchange plc's Main Market for listed securities at 8.00 a.m. today.

 

All capitalised terms in this announcement have the meaning given to them in the combined circular and prospectus dated 19 June 2020 (the "Prospectus"), unless otherwise defined in this announcement.

 

LEI: 213800VDC1BKJEZ8PV53

 

 

Enquiries

 

SIG plc

Andrew Allner, Chairman +44 (0) 114 285 6300

Steve Francis, Chief Executive Officer +44 (0) 114 285 6300

Ian Ashton, Chief Financial Officer +44 (0) 114 285 6300

 

Lazard - Lead Financial Adviser

Cyrus Kapadia / Vasco Litchfield / Nick Fowler +44 (0) 20 7187 2000

 

Jefferies International Limited - Financial Adviser, Joint Sponsor & Joint Broker

Ed Matthews / Philip Noblet / Lee Morton / Will Soutar +44 (0) 20 7029 8000

 

Peel Hunt LLP - Financial Adviser, Joint Sponsor & Joint Broker

Charles Batten / Nicholas How / Sam Cann +44 (0) 20 7418 8900

 

FTI Consulting

Richard Mountain / Susanne Yule +44 (0) 20 3727 1340

 

Important notices

Lazard & Co., Limited (Lazard) and each of Jefferies International Limited (Jefferies) and Peel Hunt LLP (Peel Hunt) (together, in the case only of Jefferies and Peel Hunt, the Joint Bookrunners), which are each authorised and regulated in the UK by the FCA, are each acting exclusively for SIG plc and no one else in connection with the contents of this announcement, the Capital Raise or any other matters referred to in this announcement and will not regard any other person as a client in relation to the Capital Raise or any other matters referred to in this announcement and will not be responsible to anyone for providing the protections afforded to their clients nor for giving advice to any other person in relation to the contents of this announcement, the Capital Raise or any other matter or arrangement referred to in this announcement. Neither Lazard nor the Joint Bookrunners are responsible for the contents of this announcement.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by either Joint Bookrunner, Lazard or by any of their respective affiliates, directors, employees, advisers or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Neither this announcement nor any copy of it nor the information contained in it and any related materials is for publication, distribution or release, in whole or in part, directly or indirectly, in or into or from the United States (including its territories and possessions, any State of the United States and the District of Columbia) (subject to certain restrictions), Australia, its territories and possessions, Canada, Japan, South Africa, Malaysia, New Zealand or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction.

The distribution of this announcement and the offering of the New Ordinary Shares may be restricted by law in certain jurisdictions.

The New Ordinary Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), or under any securities laws of any state or other jurisdiction of the United States. The New Ordinary Shares may not be offered, sold, taken up, exercised, resold, transferred or delivered, directly or indirectly, into or within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of the New Ordinary Shares in the United States.

The New Ordinary Shares to be issued or sold pursuant to the Firm Placing and Placing and Open Offer will not be admitted to trading on any stock exchange other than the London Stock Exchange.

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

Information to Distributors

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended (MiFID II); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the MiFID II Product Governance Requirements), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the New Ordinary Shares to be issued in the Capital Raise have been subject to a product approval process, which has determined that the New Ordinary Shares are: (i) compatible with an end target market of retail investors and investors who meet the criteria of professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the Target Market Assessment). Notwithstanding the Target Market Assessment, distributors should note that: the price of the New Ordinary Shares may decline and investors could lose all or part of their investment; the New Ordinary Shares to be issued in the Capital Raise provide no guaranteed income and no capital protection; and an investment in the New Ordinary Shares to be issued in the Capital Raise is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Capital Raise. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Jefferies and Peel Hunt will only procure investors who meet the criteria of professional clients and eligible counterparties.

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to, the New Ordinary Shares.

Each distributor is responsible for undertaking its own Target Market Assessment in respect of the New Ordinary Shares and determining appropriate distribution channels.

Unless the context otherwise requires, all references to time are to London time.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
LISRLMLTMTTMBFM
Date   Source Headline
17th Oct 20164:28 pmRNSDirector/PDMR Shareholding
14th Oct 201612:29 pmRNSHolding(s) in Company
11th Oct 20167:00 amRNSRetirement of FD and announcement of successor
15th Sep 20166:27 pmRNSDirector/PDMR Shareholding
2nd Sep 20164:18 pmRNSHolding(s) in Company
1st Sep 201611:29 amRNSTotal Voting Rights
26th Aug 20168:43 amRNSHolding(s) in Company
23rd Aug 20164:13 pmRNSDirector/PDMR Shareholding
16th Aug 201612:01 pmRNSDirector/PDMR Shareholding
9th Aug 20167:00 amRNSHalf-year Report
4th Aug 20168:36 amRNSBlock listing Interim Review
1st Aug 20164:42 pmRNSHolding(s) in Company
18th Jul 201611:15 amRNSDirector/PDMR Shareholding
6th Jul 20162:22 pmRNSHolding(s) in Company
4th Jul 20168:44 amRNSHolding(s) in Company
29th Jun 20162:54 pmRNSDirector/PDMR Shareholding
29th Jun 20168:41 amRNSDirector Declaration
28th Jun 20164:09 pmRNSHolding(s) in Company
21st Jun 20167:00 amRNSRefinancing of £130m private placement notes
15th Jun 20163:54 pmRNSDirector/PDMR Shareholding
6th Jun 20164:44 pmRNSHolding(s) in Company
6th Jun 201612:24 pmRNSHolding(s) in Company
25th May 20168:50 amRNSDirector Declaration
17th May 20162:07 pmRNSHolding(s) in Company
17th May 201610:54 amRNSDirector/PDMR Shareholding
16th May 201610:06 amRNSHolding(s) in Company
12th May 20162:03 pmRNSResult of AGM
12th May 20167:00 amRNSAGM Trading Statement
6th May 20169:00 amRNSNotice of Trading Update and AGM
3rd May 20169:34 amRNSTotal Voting Rights
15th Apr 20163:49 pmRNSDirector/PDMR Shareholding
11th Apr 20162:52 pmRNSDirector/PDMR Shareholding
7th Apr 201611:21 amRNSAnnual Financial Report
1st Apr 20169:07 amRNSTotal Voting Rights
15th Mar 20163:18 pmRNSDirector/PDMR Shareholding
9th Mar 20167:00 amRNSFinal Results
25th Feb 201610:12 amRNSDirector Declaration
23rd Feb 201610:31 amRNSHome Member State
18th Feb 20166:14 pmRNSHolding(s) in Company
16th Feb 201612:11 pmRNSDirector/PDMR Shareholding
4th Feb 20168:47 amRNSBlocklisting Interim Review
18th Jan 20169:16 amRNSHolding(s) in Company
15th Jan 20164:11 pmRNSDirector/PDMR Shareholding
15th Jan 20169:06 amRNSHolding(s) in Company
14th Jan 20167:00 amRNSTrading Update
13th Jan 20162:13 pmRNSHolding(s) in Company
13th Jan 20169:09 amRNSHolding(s) in Company
11th Jan 20165:27 pmRNSHolding(s) in Company
11th Jan 20163:46 pmRNSHolding(s) in Company
7th Jan 20167:00 amRNSNotification of Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.